• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子病历中识别非酒精性脂肪性肝病算法的开发与验证

Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.

作者信息

Corey Kathleen E, Kartoun Uri, Zheng Hui, Shaw Stanley Y

机构信息

Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Blake 4, Boston, MA, 02114, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Dig Dis Sci. 2016 Mar;61(3):913-9. doi: 10.1007/s10620-015-3952-x. Epub 2015 Nov 4.

DOI:10.1007/s10620-015-3952-x
PMID:26537487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4761309/
Abstract

BACKGROUND AND AIMS

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Risk factors for NAFLD disease progression and liver-related outcomes remain incompletely understood due to the lack of computational identification methods. The present study sought to design a classification algorithm for NAFLD within the electronic medical record (EMR) for the development of large-scale longitudinal cohorts.

METHODS

We implemented feature selection using logistic regression with adaptive LASSO. A training set of 620 patients was randomly selected from the Research Patient Data Registry at Partners Healthcare. To assess a true diagnosis for NAFLD we performed chart reviews and considered either a documentation of a biopsy or a clinical diagnosis of NAFLD. We included in our model variables laboratory measurements, diagnosis codes, and concepts extracted from medical notes. Variables with P < 0.05 were included in the multivariable analysis.

RESULTS

The NAFLD classification algorithm included number of natural language mentions of NAFLD in the EMR, lifetime number of ICD-9 codes for NAFLD, and triglyceride level. This classification algorithm was superior to an algorithm using ICD-9 data alone with AUC of 0.85 versus 0.75 (P < 0.0001) and leads to the creation of a new independent cohort of 8458 individuals with a high probability for NAFLD.

CONCLUSIONS

The NAFLD classification algorithm is superior to ICD-9 billing data alone. This approach is simple to develop, deploy, and can be applied across different institutions to create EMR-based cohorts of individuals with NAFLD.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)是全球慢性肝病最常见的病因。由于缺乏计算识别方法,NAFLD疾病进展及肝脏相关结局的危险因素仍未完全明确。本研究旨在设计一种用于电子病历(EMR)中NAFLD的分类算法,以建立大规模纵向队列。

方法

我们使用具有自适应LASSO的逻辑回归进行特征选择。从合作伙伴医疗保健公司的研究患者数据登记处随机选取620例患者作为训练集。为评估NAFLD的真实诊断,我们进行了病历审查,并将活检记录或NAFLD临床诊断纳入考虑。我们在模型中纳入了实验室测量值、诊断代码以及从医疗记录中提取的概念。P<0.05的变量纳入多变量分析。

结果

NAFLD分类算法包括EMR中NAFLD自然语言提及次数、NAFLD的ICD-9代码终生数量以及甘油三酯水平。该分类算法优于仅使用ICD-9数据的算法,AUC分别为0.85和0.75(P<0.0001),并导致创建了一个由8458名个体组成的新的独立队列,这些个体患NAFLD的可能性很高。

结论

NAFLD分类算法优于单独的ICD-9计费数据。这种方法易于开发、部署,可应用于不同机构,以创建基于EMR的NAFLD个体队列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f3/4761309/47692d301841/nihms735696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f3/4761309/47692d301841/nihms735696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f3/4761309/47692d301841/nihms735696f1.jpg

相似文献

1
Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.电子病历中识别非酒精性脂肪性肝病算法的开发与验证
Dig Dis Sci. 2016 Mar;61(3):913-9. doi: 10.1007/s10620-015-3952-x. Epub 2015 Nov 4.
2
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
3
Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.应用自然语言处理的增强型人工智能用于电子健康记录,以识别非酒精性脂肪性肝病患者中疾病进展风险较高的患者。
Int J Med Inform. 2019 Sep;129:334-341. doi: 10.1016/j.ijmedinf.2019.06.028. Epub 2019 Jul 6.
4
Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.退伍军人管理局人群中的非酒精性脂肪性肝病(NAFLD):使用自动化数据开发和验证NAFLD算法
Aliment Pharmacol Ther. 2014 Oct;40(8):949-54. doi: 10.1111/apt.12923. Epub 2014 Aug 26.
5
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.利用超声和肝活检对以中老年人为主的人群进行非酒精性脂肪性肝病和非酒精性脂肪性肝炎的患病率:一项前瞻性研究。
Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19.
6
The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.非侵入性评分在评估2型糖尿病患者非酒精性脂肪性肝病和晚期肝纤维化患病率中的应用
J Clin Gastroenterol. 2018 Mar;52(3):268-272. doi: 10.1097/MCG.0000000000000905.
7
Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.血清标志物模型的开发以提高非酒精性脂肪性肝病中晚期纤维化的诊断准确性:新型LINKI算法与现有算法的比较
PLoS One. 2016 Dec 9;11(12):e0167776. doi: 10.1371/journal.pone.0167776. eCollection 2016.
8
Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.非侵入性检测在临床胃肠病学实践中识别非酒精性脂肪性肝炎高风险不良结局患者的作用:专家小组建议。
Am J Gastroenterol. 2021 Feb 1;116(2):254-262. doi: 10.14309/ajg.0000000000001054.
9
Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.开发一种在电子健康记录中识别非酒精性脂肪性肝炎肝硬化病例的算法。
Dig Dis Sci. 2021 May;66(5):1452-1460. doi: 10.1007/s10620-020-06388-y. Epub 2020 Jun 13.
10
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. FibroScan-AST (FAST) 评分用于无创识别有显著活动度和纤维化的非酒精性脂肪性肝炎患者:一项前瞻性推导和全球验证研究。
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):362-373. doi: 10.1016/S2468-1253(19)30383-8. Epub 2020 Feb 3.

引用本文的文献

1
Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis Using Natural Language Processing.使用自然语言处理技术对代谢功能障碍相关脂肪性肝炎患者进行风险预测
Gastro Hep Adv. 2025 May 14;4(9):100701. doi: 10.1016/j.gastha.2025.100701. eCollection 2025.
2
Comparing the cost of cirrhosis to other common chronic diseases: A longitudinal study in a large national insurance database.肝硬化与其他常见慢性病的成本比较:一项基于大型 national 保险数据库的纵向研究。 注:原文中“national”前似乎少了个限定词,比如“national health”(国民健康)等,不然单独的“national”在这里语义不太完整。
Hepatology. 2025 Jan 6. doi: 10.1097/HEP.0000000000001206.
3
Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems.在不同医疗保健系统中使用基于机器的方法对非酒精性脂肪性肝病患者进行快速识别和表型分析。
Clin Transl Sci. 2025 Jan;18(1):e70105. doi: 10.1111/cts.70105.
4
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study.肝硬化虚弱患者的高住院率及危险因素:一项基于人群的10年队列研究
Clin Gastroenterol Hepatol. 2024 Oct 18. doi: 10.1016/j.cgh.2024.08.044.
5
Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020.通过2017 - 2020年美国国家健康与营养检查调查(NHANES)的受控衰减参数评估非酒精性脂肪性肝病的自动化机器学习模型。
Digit Health. 2024 Aug 7;10:20552076241272535. doi: 10.1177/20552076241272535. eCollection 2024 Jan-Dec.
6
Identification of hepatic steatosis among persons with and without HIV using natural language processing.利用自然语言处理技术识别有和无 HIV 感染者的肝脂肪变性。
Hepatol Commun. 2024 Jun 19;8(7). doi: 10.1097/HC9.0000000000000468. eCollection 2024 Jul 1.
7
A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis.一种自然语言处理算法可以准确地对脂肪性肝病的病理学进行分类,以估计肝硬化的风险。
Hepatol Commun. 2024 Mar 29;8(4). doi: 10.1097/HC9.0000000000000403. eCollection 2024 Apr 1.
8
Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018.2012-2018 年美国参保成年人肝硬化发病率的上升趋势。
PLoS One. 2024 Feb 26;19(2):e0298887. doi: 10.1371/journal.pone.0298887. eCollection 2024.
9
Where you live matters: Area deprivation predicts poor survival and liver transplant waitlisting.居住地很重要:地区贫困与较差的生存及肝移植候补结果相关。
Am J Transplant. 2024 May;24(5):803-817. doi: 10.1016/j.ajt.2024.02.009. Epub 2024 Feb 10.
10
Artificial Intelligence in Liver Diseases: Recent Advances.人工智能在肝脏疾病中的应用:最新进展。
Adv Ther. 2024 Mar;41(3):967-990. doi: 10.1007/s12325-024-02781-5. Epub 2024 Jan 29.

本文引用的文献

1
NAFLD: a multisystem disease.非酒精性脂肪性肝病:一种多系统疾病。
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.
2
Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.退伍军人管理局人群中的非酒精性脂肪性肝病(NAFLD):使用自动化数据开发和验证NAFLD算法
Aliment Pharmacol Ther. 2014 Oct;40(8):949-54. doi: 10.1111/apt.12923. Epub 2014 Aug 26.
3
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者血脂异常作为心血管危险因素的管理。
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1077-84; quiz e59-60. doi: 10.1016/j.cgh.2013.08.014. Epub 2013 Aug 17.
4
Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach.利用自然语言处理改善电子病历中克罗恩病和溃疡性结肠炎的病例定义:一种新的信息学方法。
Inflamm Bowel Dis. 2013 Jun;19(7):1411-20. doi: 10.1097/MIB.0b013e31828133fd.
5
Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network.基于电子病历的表型算法验证:eMERGE 网络的结果和经验教训。
J Am Med Inform Assoc. 2013 Jun;20(e1):e147-54. doi: 10.1136/amiajnl-2012-000896. Epub 2013 Mar 26.
6
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.
7
Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.基于基线时的简单心代谢危险因素预测新发脂肪肝。
BMC Gastroenterol. 2012 Jul 6;12:84. doi: 10.1186/1471-230X-12-84.
8
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
9
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.荟萃分析:非酒精性脂肪性肝病(NAFLD)自然史及肝疾病严重程度无创性检测的诊断准确性。
Ann Med. 2011 Dec;43(8):617-49. doi: 10.3109/07853890.2010.518623. Epub 2010 Nov 2.
10
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.利用超声和肝活检对以中老年人为主的人群进行非酒精性脂肪性肝病和非酒精性脂肪性肝炎的患病率:一项前瞻性研究。
Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19.